NEW YORK (GenomeWeb) – The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cellectis announced today that they will collaborate on a project that the Wyss has undertaken to recode the genome of cell lines derived from humans and other species, and to develop new tools and methods to achieve that goal.

The cell lines would be engineered to resist debilitating viral infections while carrying out their normal functions, or even perform entirely new functions, the Wyss said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.